The Latest Cardiac and Vascular News
—Independent Oxford-led data showcase the value of coronary inflammation assessment in non-contrast cardiac CT, identifying risk even in patients with zero coronary calcium— —Late-breaking ORFAN-MAESTRIA data and additional investigator-led analyses highlight broader scientific…
Investigator-led abstracts will explore new data on FAI-Score’s prognostic value, alongside emerging applications in stroke prediction and virtual biopsy of arterial inflammation OXFORD, England and STAMFORD, Conn., Aug. 24, 2026 /PRNewswire/ — Caristo Diagnostics, a global leader in AI…
Appointments to scale adoption of Caristo’s AI-powered cardiovascular technologies globally OXFORD, England and STAMFORD, Conn., July 23, 2026 /PRNewswire/ — Caristo Diagnostics, a global leader in AI-powered technologies for cardiovascular disease, today announced two additions to its…
Three of six SCCT 2026 Young Investigator Award-nominated abstracts utilize Caristo’s technologies, including—for the first time—an application of FAI-Score on non-contrast cardiac CT OXFORD, England and STAMFORD, Conn., July 8, 2026 /PRNewswire/ — Caristo Diagnostics, a global leader in…
Caristo’s flagship technology, CaRi-Heart, recognised for its groundbreaking ability to transform cardiovascular disease prevention and management Caristo joins a prestigious group of 100 global innovators chosen by the World Economic Forum to help solve major world challenges OXFORD,…
OXFORD, England and STAMFORD, Conn., April 14, 2026 /PRNewswire/ — Caristo Diagnostics, a University of Oxford spinout and a global leader in AI technology for cardiovascular disease, today announced the appointment of Board Member Stephen M. Deitsch as Chief Executive Officer (CEO),…
New OPPS and PFS reimbursement rates give hospitals, imaging centers and physicians a unified path to use AI plaque analysis starting 2026 STAMFORD, Conn., Nov. 25, 2025 /PRNewswire/ — Caristo Diagnostics, on a mission to transform the diagnosis and treatment of cardiovascular disease,…
Landmark collaboration with Caristo Diagnostics positions NCH at the forefront of preventive cardiology NCH cardiologists to present collaboration plans at American Heart Association 2025 Scientific Sessions on Nov. 8 NAPLES, Fla. and STAMFORD, Conn. , Nov. 5, 2025 /PRNewswire/ — Naples…
AMA assigns CPT codes 0992T and 0993T to Caristo’s CaRi-Heart® AI-powered analysis of perivascular fat and cardiovascular risk, which are included in the 2026 CPT® Codebook New CPT codes mark a major step toward making CaRi-Heart technology available in everyday clinical care in the U.S….
‘FORTIFY’ Selects FAI-Score™ as Primary Outcome Measure, and Caristo as Worldwide Imaging Core Lab for Coronary Inflammation and Plaque Measurement and Monitoring STAMFORD, Conn. and LOS ANGELES, Sept. 16, 2025 /PRNewswire/ — Caristo Diagnostics, on a mission to transform the diagnosis…
